Skip to main content
. 2016 Mar 27;2016:1523959. doi: 10.1155/2016/1523959

Figure 4.

Figure 4

Kaplan-Meier analyses of overall survival in the subgroups of patients with LAHS (a) and benign disease-associated HLH (b) and serum β 2-m concentrations <4.03 mg/L and ≥4.03 mg/L at diagnosis ((a) P = 0.015; (b) P = 0.177).